|
|
National Venture Capital Association
The National Venture Capital Association (NVCA) retains Content First to produce
a series of reports on the importance of the venture capital industry.
Venture Impact 2007 | Venture Impact 2004 | Venture Impact 2003 | American Made | Patient Capital
 |
The National Venture Capital Industry Association (NVCA) released its most recent edition of Venture Impact: The Economic Impact of Venture Capital Backed Companies to the U.S. Economy, in 2007 . The data were compiled by Global Insight based on a database of nearly 24,000 venture capital backed companies.
Select Facts From Venture Impact
- Together, the nation's venture capital backed companies employed just over 10 million American workers
- Venture capital backed companies generated $2.1 trillion in revenue.
- Total revenue of venture capital financed companies comprised 16.6 percent of the nation's gross domestic product (GDP) and 9 percent of U.S. private sector employment.
- California, Texas, Pennsylvania, Massachusetts, and Georgia were the top national job creators measured by venture capital backed companies headquartered in their state.
|
|
Select Facts From Venture Impact 2004: Venture Capital Benefits to the U.S. Economy
- Venture capital backed companies employed more than 10 million American workers.
- Venture capital backed companies generated $1.8 trillion in sales.
- Venture capital backed firms outperformed the national economy in overall sales growth.
- California, Texas, Pennsylvania, Massachusetts, and Georgia were the top national job creators measured by venture capital backed companies headquartered in their state.
- Venture capital backed companies employed almost 2.5 million people nationwide in 2003.
|
 |
The report, Venture Impact: The Economic Impact of the Venture Capital Industry on the U.S. Economy, was released
by NVCA in 2003 to provide policymakers, the press, and
the public with objective statistics on the importance of the venture capital industry to the U.S. economy and state economies. The data, based on a database compiled by DRI-WEFA, showed that venture backed companies contributed more to the U.S. economy than average public companies when measured by sales, federal taxes, exports and research and development expenditures.
|
|
Content
First was commissioned by the National Venture Capital
Association (NVCA) to develop a study on the benefits of venture capital investment in the life sciences, Patient Capital: How Venture Capital Innovation Drives Revolutionary Medical Innovation. The report was released in June 2007.
Patient Capital Key Findings
- The nation's most innovative medical breakthroughs have been brought to market by billions of dollars of venture capital investment in life sciences companies
- Venture backed life sciences companies include Boston Scientific, Amgen, Genentech, Genzyme, and Intuitive Surgical
- Impact of discoveries by venture capital backed life sciences companies saves millions of lives, improves medical procedures, reduces health care costs, and provides overall economic benefits to the U.S. economy
|
Client Benefits
This project illustrates how Content First created a user-friendly
report for the venture capital industry to educate key audiences,
including:
|